Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product

Tumor-infiltrating lymphocytes (TIL)-therapy in advanced melanoma is an advanced therapy medicinal product (ATMP) which, despite promising results, has not been implemented widely. In a European setting, TIL-therapy has been in use since 2011 and is currently being evaluated in a randomized controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindenberg, Melanie A., Retèl, Valesca P., van den Berg, Joost H., Geukes Foppen, Marnix H., Haanen, John B., van Harten, Wim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200372/
https://www.ncbi.nlm.nih.gov/pubmed/30300260
http://dx.doi.org/10.1097/CJI.0000000000000245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200372/
https://www.ncbi.nlm.nih.gov/pubmed/30300260
http://dx.doi.org/10.1097/CJI.0000000000000245

Ejemplares similares